This article supports SDGs 9, 11, and 17 by illustrating the opportunity for the use of electric powered vehicles as an energy source during natural disaster events.

The content aligns primarily with SDG 2 (Zero Hunger) by emphasizing sustainable agriculture as a solution to food insecurity, while also supporting SDG 12 (Responsible Consumption and Production), SDG 13 (Climate Action), and SDG 15 (Life on Land) through its focus on climate resilience, sustainable diets, and ecosystem restoration. It further contributes to SDG 1 (No Poverty) and SDG 17 (Partnerships for the Goals) by addressing the socio-economic dimensions of hunger and calling for collaborative, cross-sectoral action.

This article focuses on a key industry in ocean governance - tuna fishery - to examine how companies and governments relationship in international fishery negotiations can influence the governance of tuna fishery industry.

This chapter advances the UN SDG goals 3 and 17 by reviewing the use of cannabidiol oil for AD patients.

This chapter advances the UN SDG goals 3 and 17 discusses the effects COVID had on the lifestyle of patients with AD.

This chapter advances the UN SDG goals 3 and 17 discusses the female gender on AD risk.

This chapter advances the UN SDG goal 3 and 17 by exploring antiogensin in relation to the treatment of neurological disorders

Alzheimer's disease (AD) is a severe global public health issue because it is an irreversible neurodegeneration of the brain that impairs personality, cognition, memory, and other functions before it ultimately results in death from total brain failure.

The most prevalent type of neurogenerative condition linked to dementia, based on the current situation, is Alzheimer's Disease (AD).

Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.